Insulin use carries a high risk of hypoglycemia, also favored by portosystemic shunting; in cases treated by β-blockers, the risk is complicated by hypoglycemia unawareness, increasing the likelihood of brain damage. The gene discussed is INS; the disease is Hypoglycemia.